Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 95 of 100
Health
Brainstorm Health Daily: March 31, 2017
By
Clifton Leaf
and
Sy Mukherjee
Health
OxyContin’s Maker Wants to Use an iPhone App to Fight the Opioid Epidemic
By
Sy Mukherjee
Health
Brainstorm Health Daily: March 30, 2017
By
Clifton Leaf
and
Sy Mukherjee
Health
FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
By
Sy Mukherjee
Health
Trump’s Nominee to Lead the FDA Got Paid Millions by the Health Care Industry
By
Sy Mukherjee
Health
The FDA Just Approved the First Ever Drug to Treat Severe MS
By
Sy Mukherjee
Health
Brainstorm Health Daily: March 29, 2017
By
Clifton Leaf
and
Sy Mukherjee
Health
Sanofi, Regeneron Win FDA Approval for Eczema Drug With Multi-Billion Dollar Potential
By
Sy Mukherjee
Health
The Republican-Dominated Kansas Legislature Just Approved a Major Obamacare Provision
By
Sy Mukherjee
Health
The Patent Battle Over Revolutionary CRISPR Gene-Editing Tech Just Went Global
By
Sy Mukherjee
Health
Brainstorm Health Daily: March 28, 2017
By
Clifton Leaf
and
Sy Mukherjee
Health
Trump Is Slashing FDA Rules. Why Isn’t Big Pharma Excited?
By
Sy Mukherjee
Health
Brainstorm Health Daily: March 27, 2017
By
Clifton Leaf
and
Sy Mukherjee
Health
Here’s How Health Care Stocks Are Responding to Trumpcare’s Demise
By
Sy Mukherjee
Health
Trumpcare May Have Died But That Doesn’t Mean Obamacare Is Safe
By
Sy Mukherjee